THE EFFECT OF 48 WEEKS OF ROSIGLITAZONE ALONE VERSUS COMBINATION ROSIGILITAZONE AND METFORMIN (AVANDAMET) VERSUS COMBINATION ROSIGLITAZONE AND LOSARTAN IN THE TREATMENT OF NONALCOHOHOLIC STEATOHEPATITIS (NASH): A OPEN-LABEL PROSPECTIVE RANDOMIZED CLINICAL TRIAL

被引：0
|
作者：
Torres, Dawn M. [1 ]
Jones, Frances J. [1 ]
Williams, Christopher D. [1 ]
Harrison, Stephen [1 ]
机构：
[1] SAUSHEC, San Antonio, TX USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
185
引用
收藏
页码：390A / 391A
页数：2
相关论文
共 50 条
  • [1] OPEN-LABEL PROSPECTIVE RANDOMIZED 48 WEEK CLINICAL TRIAL: ROSIGLITAZONE VERSUS ROSIGLITAZONE AND METFORMIN (AVANDAMET) VERSUS ROSIGLITAZONE AND LOSARTAN IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Torres, D.
    Jones, F. J.
    Shaw, J.
    Williams, C.
    Ward, J. A.
    Harrison, S. A.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S7 - S8
  • [2] Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis in Humans: A 12-Month Randomized, Prospective, Open-Label Trial
    Torres, Dawn M.
    Jones, Frances J.
    Shaw, Janet C.
    Williams, Christopher D.
    Ward, John A.
    Harrison, Stephen A.
    HEPATOLOGY, 2011, 54 (05) : 1631 - 1639
  • [3] Efficacy and Effects on Lipid Metabolism of Combination Treatment With Losartan plus Hydrochlorothiazide Versus Losartan plus Amlodipine: A 48-Week Prospective, Multicenter, Randomized, Open-Label Trial
    Nishiwaki, Masato
    Hosoai, Hiroshi
    Ikewaki, Katsunori
    Ayaori, Makoto
    Yamashita, Takeshi
    Shige, Hideki
    Higashi, Kenji
    Nashida, Yukitaka
    Shimizu, Shuichi
    Kijima, Fujio
    Yokoyama, Masako
    Nakamura, Haruo
    CLINICAL THERAPEUTICS, 2013, 35 (04) : 461 - 473
  • [4] Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
    Komajda, Michel
    Curtis, Paula
    Hanefeld, Markolf
    Beck-Nielsen, Henning
    Pocock, Stuart J.
    Zambanini, Andrew
    Jones, Nigel P.
    Gomis, Ramon
    Home, Philip D.
    CARDIOVASCULAR DIABETOLOGY, 2008, 7 (1)
  • [5] Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
    Michel Komajda
    Paula Curtis
    Markolf Hanefeld
    Henning Beck-Nielsen
    Stuart J Pocock
    Andrew Zambanini
    Nigel P Jones
    Ramon Gomis
    Philip D Home
    Cardiovascular Diabetology, 7
  • [6] Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial
    Phuong Nguyen Thi Thu
    Minh Ngo Thị Huong
    Ngan Tran Thi
    Hoi Nguyen Thanh
    Khue Pham Minh
    BMC Infectious Diseases, 21
  • [7] Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial
    Phuong Nguyen Thi Thu
    Minh Ngo Thi Huong
    Ngan Tran Thi
    Hoi Nguyen Thanh
    Khue Pham Minh
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [8] Metformin plus first-line chemotherapy versus chemotherapy alone in the treatment of epithelial ovarian cancer: a prospective open-label pilot trial
    Zheng, Ya
    Zhu, Jie
    Zhang, Haiyan
    Liu, Yanmei
    Sun, Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (06) : 1349 - 1357
  • [9] Metformin plus first-line chemotherapy versus chemotherapy alone in the treatment of epithelial ovarian cancer: a prospective open-label pilot trial
    Ya Zheng
    Jie Zhu
    Haiyan Zhang
    Yanmei Liu
    Hong Sun
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1349 - 1357
  • [10] An Open label Randomized Controlled Trial to Study the Efficacy of Combination of Pentoxiphylline and Vitamin E versus Vitamin E alone in patients with Non-Alcoholic Steatohepatitis
    Kedarisetty, Chandan Kumar
    Bhardwaj, Ankit
    Kumar, Guresh
    Rastogi, Archana
    Bihari, Chhagan
    Kumar, Manoj
    Venkataraman, Jayanthi
    Sarin, Shiv
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 102 - 102
12345